Table 3.

Summary of the diagnostic performances of long non-coding RNAs in colorectal cancer.

LncRNAs	Expression	CRC cases vs. controls	AUC	Sensitivity	Specificity	Sample	Reference
BLACAT1	Up	30 vs.30	0.858	83.3%	76.7%	Serum	[162]
BCAR4	Up	76 vs.76	0.936	NA	NA	Serum	[163]
KRTAP5-4, MAGEA3 and BCAR4	-	76 vs.76	0.857	NA	NA	Serum	[163]
CRNDE-b	Up	161 vs. 222	0.921	85%	96%	Plasma	[164]
CRNDE-g	Up	161 vs. 222	0.892	80%	96%	Plasma	[164]
CRNDE-h	Up	161 vs. 222	0.888	80%	96%	Plasma	[164]
NEAT1	Up	100 vs. 100	0.787/0.871	69%/70%;	79%/96%	Blood	[165]
91H	Up	76 vs.76	0.870	84.48%	80.36%	Plasma	[166]
PVT-1	Up	76 vs.76	0.786	68.97%	82.14%	Plasma	[166]
MEG3	Down	76 vs.76	0.819	75.86%	82.14%	Plasma	[166]
GAS5	Up	76 vs.76	0.642	63.79%	62.5%	Plasma	[166]
CCAT1-L	Up	76 vs.76	0.748	75.86%	73.21%	Plasma	[166]
91H, PVT-1 and MEG3	-	76 vs.76	0.877	82.76%	78.57%	Plasma	[166]
LINC00654	Up	114 vs.58	0.734	NA	NA	Plasma	[167]
LINC00909	Up	114 vs.58	0.886	NA	NA	Plasma	[167]
SNGH11	Up	114 vs.58	0.868	NA	NA	Plasma	[167]
ZFAS1	Up	114 vs.58	0.850	NA	NA	Plasma	[167]
ZFAS1, SNHG11, LINC00909 and	-		0.937	NA	NA	Plasma	[167]
LINC00654
LINC02418	Up	125 vs. 125	0.8978	95.2%	66.4%	Serum	[169]
RP11-296E3.2	Up	60 CRC	0.663	69.0%	62.1%	Plasma	[171]
RP11-296E3.2 and CEA	-	60 CRC	0.722	72.4%	71.4%	Plasma	[171]
BANCR, NR_026817, NR_029373, and NR_034119	-	120 vs. 120	0.881	89.17%	75.83%	Serum and tissue	[168]